- Home
- CNTB vs ANIK Comparison
CNTB vs ANIK Comparison
Compare CNTB & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTB
- ANIK
- Stock Information
- Founded
- CNTB 2012
- ANIK 1983
- Country
- CNTB United States
- ANIK United States
- Employees
- CNTB N/A
- ANIK N/A
- Industry
- CNTB Biotechnology: Pharmaceutical Preparations
- ANIK Medical/Dental Instruments
- Sector
- CNTB Health Care
- ANIK Health Care
- Exchange
- CNTB Nasdaq
- ANIK Nasdaq
- Market Cap
- CNTB 114.8M
- ANIK 133.1M
- IPO Year
- CNTB 2021
- ANIK 1993
- Fundamental
- Price
- CNTB $1.60
- ANIK $8.94
- Analyst Decision
- CNTB Strong Buy
- ANIK Buy
- Analyst Count
- CNTB 2
- ANIK 1
- Target Price
- CNTB $7.50
- ANIK $15.00
- AVG Volume (30 Days)
- CNTB 156.9K
- ANIK 101.5K
- Earning Date
- CNTB 09-05-2025
- ANIK 10-30-2025
- Dividend Yield
- CNTB N/A
- ANIK N/A
- EPS Growth
- CNTB N/A
- ANIK N/A
- EPS
- CNTB N/A
- ANIK N/A
- Revenue
- CNTB $1,965,000.00
- ANIK $114,548,000.00
- Revenue This Year
- CNTB N/A
- ANIK N/A
- Revenue Next Year
- CNTB N/A
- ANIK $5.33
- P/E Ratio
- CNTB N/A
- ANIK N/A
- Revenue Growth
- CNTB N/A
- ANIK 16.52
- 52 Week Low
- CNTB $1.55
- ANIK $7.87
- 52 Week High
- CNTB $2.20
- ANIK $26.00
- Technical
- Relative Strength Index (RSI)
- CNTB 42.21
- ANIK 49.07
- Support Level
- CNTB $1.55
- ANIK $8.56
- Resistance Level
- CNTB $1.76
- ANIK $8.89
- Average True Range (ATR)
- CNTB 0.18
- ANIK 0.33
- MACD
- CNTB -0.03
- ANIK 0.03
- Stochastic Oscillator
- CNTB 9.92
- ANIK 48.35
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.